MedTrace Logo

Safety and Effectiveness Study of the VEGA UV-A System for Cross-linking in Eyes With Keratoconus and Ectasia

NCT01398852 · Status: TERMINATED · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 500

Last updated 2022-06-29

Study results available
· View outcomes & findings →

Summary

The purpose of this research study is to evaluate the long tern safety and effectiveness of cross-linking in eyes with keratoconus and ectasia.

Conditions

  • Keratoconus and Ectasia

Interventions

DRUG

Riboflavin

Riboflavin is a solution that will be delivered to the treatment area

DEVICE

VEGA UV-A Illumination System

This is a portable electronic device designed to deliver a dose of UV-A light to the treatment area

Sponsors & Collaborators

  • Topcon Medical Systems, Inc.

    lead INDUSTRY

Study Design

Allocation
NA
Purpose
OTHER
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
12 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2010-12-31
Primary Completion
2012-07-31
Completion
2012-07-31

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01398852 on ClinicalTrials.gov